Leadership Team

Jacques Boschung serves as the President and General Manager of Inovalon’s Payer business, providing a portfolio of industry-leading cloud-based SaaS platform solutions empowering data-driven healthcare for a wide array of payer organizations. In this role, Mr. Boschung leads and is responsible for the management, product portfolio, delivery, operations, sales, client success, and overall performance of Inovalon’ payer business.

Mr. Boschung has extensive experience with leading large-scale technology organizations through periods of expansion and high growth. Prior to joining Inovalon, he served in several executive roles within Dell Technologies from 2004 through 2018, most recently servicing as Senior Vice President responsible for Dell Technologies Global Alliances and the $1.4 billion business of Dell EMC's Telco partnerships within the EMEA regions. Prior to this role, Jacques Boschung was Vice President and General Manager of the 2,000 associates across 18 countries comprising the $1.5 billion business of Dell Technologies Western Europe. Before his time at Dell Technologies, Mr. Boschung held various executive, management, and business development positions within technology organizations including HP and IBM.

Jacques Boschung holds a BS and Masters in Physics from the University of Lausanne and conducted his master’s thesis at the Laboratory for Nuclear Engineering of the Swiss Institute of Technology.

Matt Brow serves as the president and general manager of Inovalon’s Pharmacy, Life Sciences and Advisory business. In this role, Mr. Brow leads the organization’s focus on bringing data-enabled strategic guidance and tools to the full array of healthcare companies – from pharmacy and life sciences, to managed care and providers. Unique to the Company’s data-driven advisory business, Avalere, and Inovalon’s cloud-based pharmacy platform business is the ability to combine analytical insights informed by billions of medical events with industry-leading subject matter and policy expertise, together powering configurations of the Inovalon ONE® Platform and ScriptMed® Platform to bring resulting solutions to the marketplace in large-scale. Mr. Brow has extensive experience managing cross-functional teams and has engaged internal and external healthcare stakeholders to find consensus and achieve stable business growth. Prior to his current role spanning Inovalon’s pharmacy, life sciences, and advisory services business, Mr. Brow was responsible for its Avalere advisory business.

Prior to joining Inovalon in 2017, Mr. Brow served as Senior Vice President of Operations for the US Oncology Network at McKesson Specialty Health, and Vice President and General Manager of Vantage Oncology southeast region. Previously, Mr. Brow held roles at McKesson and its predecessor company, US Oncology, where he led public policy; mergers and acquisitions; business development; go-to-market strategy; sales; reimbursement strategy; federal and state government relations; and communications. Prior to joining US Oncology, he served as a consultant, advising clients on state government affairs strategy across a wide-range of healthcare and political issues.

Mr. Brow has published widely in peer-reviewed and professional journals on healthcare policy, the Affordable Care Act, cancer care quality, and value-based care. He holds a BA in history and political science from the University of Richmond.

Mrs. Keeneth is a Vice President and serves as the Chief Information Security Officer for Inovalon. In this role, Mrs. Keeneth is responsible for managing the Company’s information security program consisting of security risk, security governance, policy, application security, contingency program, enterprise incident response, cybersecurity, security operations, security tool administration, corporate security, physical security, insider threat, vulnerability management, vendor oversight program, and security awareness. Mrs. Keeneth leads a team of high performing information security professionals to support Inovalon’s strategic initiatives pertaining to relevant security measures, managing risks, implementing policies and controls, and generating overall awareness. Mrs. Keeneth has more than 16 years of experience performing various security advisory and leadership roles.

Prior to joining Inovalon in 2010, Mrs. Keeneth served in several strategic roles at management consulting firms, DRT Strategies and BearingPoint, supporting clients in federal, regulatory, and real estate industries. This experience includes extensive knowledge and application of information security and compliance, security governance, policy, and risk management within the federal government and private sectors.

Mrs. Keeneth holds a master’s degree from the University of Virginia in Management of Information Technology and a bachelor’s degree from George Mason University in Finance.

Dr. Kilian serves as the Chief Medical Officer (CMO) for Inovalon. In this role, Dr. Kilian is responsible for the oversight of the medical directors of the Company, the clinical content and design of the Company’s software and analytics, and the clinical training, quality, policies, oversight, and compliance of associated operations. For more than a decade, Dr. Kilian has led a team of clinical personnel who bring the latest best practices and evidence-based clinical standards to Inovalon’s products and services. Dr. Kilian is well known throughout the healthcare community as an expert on the application of data, software, and analytics to the benefit of clinical protocols, care guidelines, real-world healthcare clinical workflow, and regulatory policy guidelines adherence. Most recently, Dr. Kilian has been recognized with the Healthcare Business Women’s Association 2020 Luminary award.

Prior to joining Inovalon in 2007, Dr. Kilian was in clinical practice with Johns Hopkins Community Physicians, where she served as Medical Director with responsibilities including patient care, clinical training of medical students and residents, and clinical oversight of a multispecialty practice.

Dr. Kilian graduated summa cum laude from Washington and Lee University and earned her doctorate in medicine from Tufts University School of Medicine. She completed her residency in Internal Medicine at The Johns Hopkins Hospital in Baltimore, Maryland.

Mr. Meadows serves as the President and General Manager of the Inovalon Provider business unit providing a portfolio of leading cloud-based SaaS solutions empowering healthcare providers to achieve improvements in administrative, cost, care, and quality goals. In this role, Mr. Meadows is responsible for the overall management, operation, and performance of the Provider business unit. Prior to this role, Mr. Meadows served in several roles during his nearly 12-year tenure with the Company, leading both the commercial and customer operations functions of the Company. Mr. Meadows also played an instrumental role in leading ABILITY, acquired by Inovalon in 2018, from its venture stage through a successful two private equity recapitalizations and its acquisition by Inovalon. Most recently, Mr. Meadows served as the Executive Vice President and Chief Revenue Officer of ABILITY where he was responsible for ABILITY’s sales, marketing, product management, and clearinghouse operations. Mr. Meadows brings more than 25 years of sales, marketing, operations, and business development leadership experience within the healthcare technology industry in both private and public companies.

Prior to joining ABILITY in 2010, Mr. Meadows served as Senior Vice President of Sales and Business Development for Mirixa Corporation, a leading provider of technology and clinical services for pharmacies and health plans. Mr. Meadows previously held leadership roles at Sage Software, WebMD/Emdeon, and Medical Manager Corporation. During this time, he had responsibility for developing and leading the clinical and administrative transactions sales business units and reseller programs.

Mr. Meadows is a graduate of Washington and Lee University, Williams School of Commerce, with a degree in politics.

Ms. Olsen serves as Chief People Officer for Inovalon. In this role, Ms. Olsen is responsible for all aspects of the strategy and processes of building, developing, maintaining, engaging, and supporting Inovalon’s exceptional team of personnel and their achievement of the Company’s mission, professional growth, and fulfillment.

Prior to joining Inovalon, Ms. Olsen served as the Chief Integration and People Officer for OnRobot, a global robotics technology company based in Europe, where she was responsible for driving all operational and cultural integration activities for corporate acquisitions, human resources, and global sales coverage expansion. Prior to this role, Ms. Olsen served as Vice President, Strategy and Go-to-Market for the EMEA Enterprise of Dell EMC. In this role, Ms. Olsen was responsible for the integration activities of Dell EMC across the EMEA Enterprise and the associated go-to-market strategy for the associated $4 billion business covering 1,400 enterprise accounts across 38 countries. Prior to this role, Ms. Olsen served in a number of expanding management, support, and operational roles at EMC Corporation, a global leader in enabling business and service providers to transform their operations and deliver IT as a service, from 1998 through 2016. During this time, Ms. Olsen served in roles of Market Growth and International Strategy, Strategic Operations, Go-to-Market, and Human Resources for individual countries, regions, and global applications. While at EMC, Ms. Olsen also introduced, deployed, and brought to fruition the concept of BUSINESSRELEVANT HR. Prior to her time at EMC, Ms. Olsen worked for the law firm of Skadden Arps in Boston, Massachusetts, supporting its global corporate mergers and acquisitions practice.

Ms. Olsen graduated with a Bachelors of Arts Degree, Summa Cum Laude, in Political Science and Psychology from Northeastern University in Boston, Massachusetts.

Mr. Creehan serves as a Fellow of Pharmacy Solutions at Inovalon, a role created to recognize Mr. Creehan for a distinguished career at Inovalon and Creehan. In this role, Mr. Creehan supports key pharmacy software platform relationships, industry thought-leadership, and product strategy, design, and development initiatives at Inovalon.

Mr. Creehan previously served as president and general manager of Inovalon’s pharmacy software business where he led the Company’s design, development, advancement, and support of data-driven pharmacy solutions.

Mr. Creehan has a 25 year history of pharmacy technology solution development and implementation and is the founder of Creehan and company, the industry’s leading provider of enterprise software for the pharmacy marketplace. After combining Creehan and company with Inovalon in 2016, Mr. Creehan has led the strategy and innovation of the Company’s next generation pharmacy platform solution. Leveraging a modular cloud-based architecture, and the data, connectivity, and analytical capabilities of the Inovalon ONE® Platform, ScriptMed® Cloud is the industry’s most advanced enterprise pharmacy platform.

Mr. Creehan has a proven track record for driving business growth from start-up pharmacies to several Fortune 500 clients through technology and innovation, and is an established industry thought leader. He has played an active role in advancing technology and automation for clinical decision support, care coordination, pharmacy practice, and pharmaceutical distribution. Providing the strategy, vision, and architecture for the company’s technologies, Mr. Creehan has lead the company to the number one market position in specialty pharmacy, and establishment of leading technology for driving clinical quality and patient outcomes in pharmacy.

Mr. Creehan holds a B.S. in Information Systems from Robert Morris University and is a graduate of the Entrepreneurial Management Program at Carnegie Mellon University. He is active in the pharmacy community and is a member of several industry associations.

Mr. Rizzo serves as a Fellow of Innovation for Inovalon, a role created to recognize Mr. Rizzo for a distinguished career at Inovalon. In this role, Mr. Rizzo mentors emerging leaders within the Company and supports product strategy, innovation, and go-to-market initiatives of the Company.

Prior to this role, Mr. Rizzo served in many key roles at Inovalon since his joining the Company in 2002, and most recently as Chief Innovation Officer for Inovalon until 2016. In this role, Mr. Rizzo was responsible for the coordination and oversight of all product development and material product updates and expansions of capability; including design, functionality, development, quality testing processes, and modularized rollouts and operational expansions. Mr. Rizzo was also responsible for all aspects of the Company’s dataset assets, including processes to support and achieve the high integrity, reliability, and security; accuracy and efficiency of integration; comprehensive policies and procedures for the access and utilization; and ultimate realization of value for the Company, clients, and the healthcare community. In addition to these roles, Mr. Rizzo served as the Company’s Security Officer and served in a number of key roles at Inovalon, including the Company’s Chief Product Officer, and was responsible for all major product roll outs since the Company first started major operations.

Prior to joining Inovalon, Mr. Rizzo served as Vice President of Product Development for Founding Advisors, Inc., a specialized management consulting firm. In the service of Founding Advisors, Mr. Rizzo served in various product development roles on behalf of Founding Medical Informatics, Inc. and the Medical Reliance Group, LLC, including leading the technology and software design and development of the core products of Medical Site Reviewers.

Prior to joining Founding Advisors, Mr. Rizzo was a senior consultant at Arthur Andersen, LLP, where he advised clients in the healthcare, telecommunications, and insurance industries. In his capacity as lead analyst, Mr. Rizzo performed in-depth data analysis and financial investigations of health and life insurance companies in order to evaluate appropriate recapture of reinsurance receivables and government coverage for customers of life insurance companies in liquidation. While at the firm, he also performed in-depth industry financial investigations in support of clients’ strategic expansion and investment decisions.

In addition to his Fellow role at Inovalon, Mr. Rizzo serves as a trustee at Loyola University Maryland, where he graduated Summa Cum Laude with a Bachelor of Arts degree in Business Administration, and is highly active in a number of philanthropic organizations serving disadvantages communities in Maryland. Additionally, Mr. Rizzo holds the Chartered Financial Analyst designation and is active within the entrepreneurial, venture capital, and private equity community throughout the mid-Atlantic region.

Mr. Wychulis serves as a Fellow for the Payer business at Inovalon, a role created to leverage Mr. Wychulis’ deep industry experience, expertise, and distinguished career within the marketplace and at Inovalon. In this role, Mr. Wychulis focuses on industry trends and specific strategic client opportunities, relationships, operations, and support for Inovalon’s Payer business.

Prior to this role, Mr. Wychulis was the president and member of the Executive Leadership Team of Inovalon, where he was responsible for the oversight of the Company’s day-to-day operations across its business units and the related industry insight support, client engagement, and strategic relationships. Prior to joining Inovalon in 2014, Mr. Wychulis served as the President of the WellPoint New York government program health plan, HealthPlus, an Amerigroup company, where he was responsible for the full P&L management of the company’s $1.9 billion product portfolio within the New York region. Mr. Wychulis was responsible for oversight of medical management, quality improvement, finance, compliance, human resources, government relations, provider contracting, marketing, enrollment, strategic planning, and the managed long-term care product. Mr. Wychulis played a pivotal role in working with state regulators in transforming New York’s Medicaid delivery system through the state’s Medicaid Redesign Team (MRT), worked on complex premium rate setting issues within the state, and served on the state’s quality incentive committee for the long-term care populations. Under Mr. Wychulis’ direction, the plan realized a 300-percent growth in membership and a 600-percent increase in premium revenue. In 2013, he was awarded WellPoint’s Pinnacle Award, the company’s highest management award. In the same year, HealthPlus was the most profitable of the 20 WellPoint government program plans, while maintaining an upper tier quality and outcome ranking, and achieving NCQA accreditation status for the plan.

Prior to joining WellPoint/Amerigroup, Mr. Wychulis served as President and CEO of the Florida Association of Health Plans, where he expanded the Association from 8 to 26 plans in 4 years. Mr. Wychulis was responsible for driving the successful development of public policy and legislation that resulted in a significant expansion of covered lives and an increase in hundreds of millions of dollars in additional revenue to the Florida managed care plans. He facilitated critical strategic relationships with the hospital, medical, and health advocacy community and associations. Mr. Wychulis also served as President and CEO of HealthPlan Southeast, a North Florida managed care company comprised of state employee, commercial, and Medicaid/CHP contracts. Mr. Wychulis was instrumental in improving the plan’s performance and positioning it to serve as the base for the successful acquisition and integration of multiple Florida managed care organizations that are now Coventry/Aetna Florida.

Mr. Wychulis received his Bachelor of Political Science degree from the City College of New York and his Master of Health Administration and Planning from the Wagner School of Public Administration at New York University.